Safety, pharmacodynamics, and antiviral activity of selgantolimod in viremic patients with chronic hepatitis B virus infection

Harry L. Janssen, Young-Suk Lim, Hyung Joon Kim, Leonard Sowah, Cheng-Hao Tseng, Carla S. Coffin, Magdy Elkhashab, Sang Hoon Ahn, Anh-Hoa Nguyen, Diana Chen, Jeffrey J. Wallin, Simon P. Fletcher, Circe McDonald, Jenny C. Yang, Anuj Gaggar, Diana M. Brainard, Scott Fung, Yoon Jun Kim, Jia-Horng Kao, Wan-Long Chuang, Anna E. Brooks, P. Rod Dunbar

Open source

DOI
10.1016/j.jhepr.2023.100975
Published
2024-02
Container
JHEP Reports
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jhepr.2023.100975,
  title = {Safety, pharmacodynamics, and antiviral activity of selgantolimod in viremic patients with chronic hepatitis B virus infection},
  author = {Harry L. Janssen and Young-Suk Lim and Hyung Joon Kim and Leonard Sowah and Cheng-Hao Tseng and Carla S. Coffin and Magdy Elkhashab and Sang Hoon Ahn and Anh-Hoa Nguyen and Diana Chen and Jeffrey J. Wallin and Simon P. Fletcher and Circe McDonald and Jenny C. Yang and Anuj Gaggar and Diana M. Brainard and Scott Fung and Yoon Jun Kim and Jia-Horng Kao and Wan-Long Chuang and Anna E. Brooks and P. Rod Dunbar},
  year = {2024},
  journal = {JHEP Reports},
  doi = {10.1016/j.jhepr.2023.100975},
  url = {https://doi.org/10.1016/j.jhepr.2023.100975}
}

RIS

TY  - JOUR
TI  - Safety, pharmacodynamics, and antiviral activity of selgantolimod in viremic patients with chronic hepatitis B virus infection
AU  - Harry L. Janssen
AU  - Young-Suk Lim
AU  - Hyung Joon Kim
AU  - Leonard Sowah
AU  - Cheng-Hao Tseng
AU  - Carla S. Coffin
AU  - Magdy Elkhashab
AU  - Sang Hoon Ahn
AU  - Anh-Hoa Nguyen
AU  - Diana Chen
AU  - Jeffrey J. Wallin
AU  - Simon P. Fletcher
AU  - Circe McDonald
AU  - Jenny C. Yang
AU  - Anuj Gaggar
AU  - Diana M. Brainard
AU  - Scott Fung
AU  - Yoon Jun Kim
AU  - Jia-Horng Kao
AU  - Wan-Long Chuang
AU  - Anna E. Brooks
AU  - P. Rod Dunbar
PY  - 2024
JO  - JHEP Reports
DO  - 10.1016/j.jhepr.2023.100975
UR  - https://doi.org/10.1016/j.jhepr.2023.100975
ER  - 

APA

Janssen, H. L., Lim, Y., Kim, H. J., Sowah, L., Tseng, C., Coffin, C. S., Elkhashab, M., Ahn, S. H., Nguyen, A., Chen, D., Wallin, J. J., Fletcher, S. P., McDonald, C., Yang, J. C., Gaggar, A., Brainard, D. M., Fung, S., Kim, Y. J., Kao, J., Chuang, W., Brooks, A. E., & Dunbar, P. R. (2024). Safety, pharmacodynamics, and antiviral activity of selgantolimod in viremic patients with chronic hepatitis B virus infection. JHEP Reports. https://doi.org/10.1016/j.jhepr.2023.100975

Source records